A Comparison of Bowel Preparation between 2L ascorbic acid mixed PEG and combination of 1L Ascorbic acid mixed PEG with Resolor

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0002409

Enrollment

260

Registered

2017-08-04

Start date

2017-02-06

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : It is manditory to do the bowel preparation before the colonoscopy. Conventional method is PEG split-dose regmen, that the patient drink 1L of PEG-Asc at 7pm the evening the day before colonosc

s tolerability in both groups.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients between the ages of 18 and 80 years who were scheduled to undergo colonoscopy were included.

Exclusion criteria

Exclusion criteria: (i) chronic kidney disease, (ii) severe heart failure (New York Heart Association [NYHA] class III or IV), (iii) uncontrolled hypertension (systolic pressure =170 mm Hg, diastolic pressure =100 mm Hg), (iv) severe constipation, (v) any bowel resection, (vi) significant gastroparesis, or (vii) suspected bowel obstruction or perforation.

Design outcomes

Primary

Measure	Time frame
cleansing quality of bowel preparation(Boston scale, Aronchic score)	—

Secondary

Measure	Time frame
patient tolerability	—

Countries

Korea, Republic of

Contacts

Public ContactSeong Ji Choi

Korea University Anam Hospital

coolandy03@hanmail.net+82-2-920-6555

Outcome results